News of Note—Fresenius recalls 163 lots of sodium chloride

Cancer in newspaper clipping
(Pixabay)

> Fresenius Kabi USA is voluntarily recalling 163 lots of Sodium Chloride Injection, because the labels incorrectly state that the stoppers do not contain latex. Release

> Ian Hudson, M.D., chief executive of the Medicines and Healthcare Products Regulatory Agency, has announced he will retire from MHRA in September 2019. Pharmafield article

> CDMO Dalton Pharma Services has a drug development and manufacturing services agreement with stem cell biotech ExCellThera for formulation and fill/finish services at its plant in Toronto, Canada. Release

> Oxford BioMedica will invest £4 million to build digital and robotics capabilities to increase capacity, reduce the cost of manufacturing and reduce waste in its cell manufacturing. Release

Suggested Articles

Pfizer will exit its Perth, Australia sterile injectables manufacturing site by 2024 as part of a global production reorganization effort.

GlaxoSmithKline has sold off its Poznań, Poland, manufacturing site and 700 workers to CDMO Delpharm as part of a global asset pare-down.

Merck & Co. will build a new North Carolina plant to triple production of TICE BCG, a bladder cancer drug plagued by chronic shortages.